ArticleFrontiers in surgery2026
Impact of femoral mediolateral diameter on femoral component selection during total knee arthroplasty and its effect on postoperative knee function and pain: a retrospective cohort study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the influence of different intraoperative reference dimensions on femoral component selection during total knee arthroplasty (TKA) and to compare the postoperative knee function, pain, and radiographic outcomes between two sizing strategies when the femoral mediolateral (ML) and anteroposterior (AP) diameters are discrepant. Methods: This retrospective cohort study included 86 patients (86 knees) with primary knee osteoarthritis who underwent TKA. Patients were allocated to two groups based on the intraoperative femoral sizing reference: Group A ( Results: Both groups achieved significant improvement in HSS score, VAS score, and knee ROM at each follow-up time point compared with preoperative values (all Conclusion: TKA remains an effective treatment for end-stage knee osteoarthritis. In Asian patients with an ML/AP ratio greater than 1.13, choosing a femoral component one to two sizes larger than that predicted by the AP reference appropriately increases distal mediolateral coverage without adversely affecting one-year functional outcomes or anterior knee pain, and significantly reduces radiographic shadowing in the uncovered distal femoral area. This strategy deserves consideration in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.